These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17225715)

  • 1. Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis.
    Meltzer EO
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):12-21. PubMed ID: 17225715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.
    Wingertzahn MA; Derebery MJ; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S18-24. PubMed ID: 18307840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis.
    Mahadevia PJ; Shah S; Leibman C; Kleinman L; O'Dowd L
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):345-50. PubMed ID: 15521370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?
    Yawn B
    MedGenMed; 2006 Jan; 8(1):23. PubMed ID: 16915153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of intranasal corticosteroid use in allergic rhinitis: benefits, costs, and patient preferences.
    Dupclay L; Doyle J
    Am J Manag Care; 2002 Sep; 8(13 Suppl):S335-40. PubMed ID: 12243450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal corticosteroids topical characteristics: side effects, formulation, and volume.
    Petty DA; Blaiss MS
    Am J Rhinol Allergy; 2013; 27(6):510-3. PubMed ID: 24274228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids.
    Blaiss MS
    Curr Med Res Opin; 2008 Mar; 24(3):821-36. PubMed ID: 18257976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
    Khanna P; Shah A
    Am J Rhinol; 2005; 19(3):316-21. PubMed ID: 16011141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
    Bachert C; El-Akkad T
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nasal corticosteroids in the treatment of rhinitis.
    Meltzer EO
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):545-60. PubMed ID: 21737042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal steroid sprays in the treatment of rhinitis: is one better than another?
    Waddell AN; Patel SK; Toma AG; Maw AR
    J Laryngol Otol; 2003 Nov; 117(11):843-5. PubMed ID: 14670141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
    Derendorf H; Meltzer EO
    Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?
    Keith PK; Scadding GK
    Curr Med Res Opin; 2009 Aug; 25(8):2021-41. PubMed ID: 19569975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
    Nathan RA
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic options for allergic rhinitis: back to the future with intranasal corticosteroid aerosols.
    Carr WW
    Am J Rhinol Allergy; 2013; 27(4):309-13. PubMed ID: 23816748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should intranasal corticosteroids be used for the treatment of ocular symptoms of allergic rhinoconjunctivitis? A review of their efficacy and safety profile.
    Lightman S; Scadding GK
    Int Arch Allergy Immunol; 2012; 158(4):317-25. PubMed ID: 22488416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclesonide, a hypotonic intranasal corticosteroid.
    Neffen H; Wingertzahn MA
    Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azelastine and olopatadine in the treatment of allergic rhinitis.
    Kaliner MA
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.
    Berger WE; Godfrey JW; Slater AL
    Expert Opin Drug Deliv; 2007 Nov; 4(6):689-701. PubMed ID: 17970670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
    Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.